Risk factors for treatment (tx) toxicity and discontinuation among patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) on androgen receptor targeted therapy (ART).
| Publicado en: | Journal of Clinical Oncology Vol. 41; pp. 135 - 136 |
|---|---|
| Autores principales: | , , , , , , , , |
| Formato: | Journal Article |
| Publicado: |
American Society of Clinical Oncology
2/21/2023 Supplement
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| Descripción no disponible. |